Search Results - "KAZLAUSKAITE, Nijolė"

Prediction of Response in Cancer Immunotherapy by CHARACIEJUS, Dainius, JACOBS, John J. L, PASUKONIENE, Vita, KAZLAUSKAITE, Nijolė, DANILEVICIUTE, Vita, MAURICAS, Mykolas, DEN OTTER, Willem

“…This review focuses on the relationship between pre-treatment immune parameter values and outcome of immunotherapy of cancer patients. The evidence presented…”
Get full text

CD8(high)CD57(+) T-cell population as an independent predictor of response to chemoradiation therapy in extensive-stage small cell lung cancer by Dobrovolskienė, Neringa T, Cicėnas, Saulius, Kazlauskaitė, Nijolė, Mišeikytė-Kaubrienė, Edita, Krasko, Jan A, Ostapenko, Valerijus, Pašukonienė, Vita, Strioga, Marius M

“…Tangible clinical benefit is achieved in only a relatively small proportion of extensive-stage small cell lung cancer (SCLC) patients receiving current…”
Get full text

Quantitative changes within the peripheral blood CD8highCD57+ T-cell subpopulation of patients with advanced renal cell carcinoma by Strioga, Marius, Pašukonienė, Vita, Dobrovolskienė, Neringa, Petraitis, Tadas, Kazlauskaitė, Nijolė, Darinskas, Adas, Jokubauskienė, Lina, Characiejus, Dainius

“…Background. Antitumor immunotherapy strategies, such as cytokine- based or cell-based immunotherapies, are designed to activate immune response against cancer…”
Get full text

A method to estimate cell cycle time and growth fraction using bromodeoxyuridine-flow cytometry data from a single sample by Eidukevicius, Rimantas, Characiejus, Dainius, Janavicius, Ramunas, Kazlauskaite, Nijole, Pasukoniene, Vita, Mauricas, Mykolas, Den Otter, Willem

“…Presently available flow cytometric methods of bromodeoxyuridine (BrdUrd) labelling do not provide information on the cell cycle time (TC) and the growth…”
Get full text

Correction: a method to estimate cell cycle time and growth fraction using bromodeoxyuridine-flow cytometry data from a single sample by Eidukevicius, Rimantas, Characiejus, Dainius, Janavicius, Ramunas, Kazlauskaite, Nijole, Pasukoniene, Vita, Mauricas, Mykolas, Den Otter, Willem

Get full text

CD8highCD57+ T-cell population as an independent predictor of response to chemoradiation therapy in extensive-stage small cell lung cancer by Dobrovolskienė, Neringa T., Cicėnas, Saulius, Kazlauskaitė, Nijolė, Mišeikytė-Kaubrienė, Edita, Krasko, Jan A., Ostapenko, Valerijus, Pašukonienė, Vita, Strioga, Marius M.

“…•We analysed peripheral blood immune parameters in extensive-stage SCLC patients.•Patients received either chemotherapy alone, or chemoradiotherapy or best…”
Get full text

CD8high CD57+ T-cell population as an independent predictor of response to chemoradiation therapy in extensive-stage small cell lung cancer by Dobrovolskienė, Neringa T, Cicėnas, Saulius, Kazlauskaitė, Nijolė, Mišeikytė-Kaubrienė, Edita, Krasko, Jan A, Ostapenko, Valerijus, Pašukonienė, Vita, Strioga, Marius M

“…Highlights • We analysed peripheral blood immune parameters in extensive-stage SCLC patients. • Patients received either chemotherapy alone, or…”
Get full text

Predictive value of CD8highCD57+ lymphocyte subset in interferon therapy of patients with renal cell carcinoma by Characiejus, Dainius, Pasukoniene, Vita, Kazlauskaite, Nijole, Valuckas, Konstantinas P, Petraitis, Tadas, Mauricas, Mykolas, Den Otter, Willem

“…The aim of this retrospective study was to evaluate the significance of pre-treatment levels of peripheral blood lymphocyte subsets for survival of renal cell…”
Get more information

Erratum to: a method to estimate cell cycle time and growth fraction using bromodeoxyuridine-flow cytometry data from a single sample by Eidukevicius, Rimantas, Characiejus, Dainius, Janavicius, Ramunas, Kazlauskaite, Nijole, Pasukoniene, Vita, Mauricas, Mykolas, Den Otter, Willem

Get full text